PDL grabs royalties, Depomed gets cash in diabetes drug deal
October 21, 2013 at 17:32 PM EDT
PDL BioPharma Inc. will buy the royalty rights to a portfolio of type 2 diabetes drugs and experimental therapies licensed by Depomed Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|